603 related articles for article (PubMed ID: 28784305)
1. Dexmedetomidine (DEX) protects against hepatic ischemia/reperfusion (I/R) injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice.
Chen Z; Ding T; Ma CG
Biochem Biophys Res Commun; 2017 Nov; 493(2):1143-1150. PubMed ID: 28784305
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
Zhao Y; Kong GY; Pei WM; Zhou B; Zhang QQ; Pan BB
Eur Cytokine Netw; 2019 Sep; 30(3):88-97. PubMed ID: 31957703
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia/reperfusion injury: An in vivo and in vitro study.
Chen L; Cao J; Cao D; Wang M; Xiang H; Yang Y; Ying T; Cong H
Life Sci; 2019 Oct; 235():116553. PubMed ID: 31185237
[TBL] [Abstract][Full Text] [Related]
5. STIM1 deficiency protects the liver from ischemia/reperfusion injury in mice.
Li Y; Lou C; Wang W
Biochem Biophys Res Commun; 2018 Feb; 496(2):422-428. PubMed ID: 29305862
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine attenuates spinal cord ischemia-reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits.
Sun Z; Zhao T; Lv S; Gao Y; Masters J; Weng H
J Transl Med; 2018 Jul; 16(1):209. PubMed ID: 30031397
[TBL] [Abstract][Full Text] [Related]
8. Different doses of dexmedetomidine reduce plasma cytokine production, brain oxidative injury, PARP and caspase expression levels but increase liver oxidative toxicity in cerebral ischemia-induced rats.
Akpınar O; Nazıroğlu M; Akpınar H
Brain Res Bull; 2017 Apr; 130():1-9. PubMed ID: 28007581
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine protects intestinal ischemia-reperfusion injury via inhibiting p38 MAPK cascades.
Liu XM; Chen QH; Hu Q; Liu Z; Wu Q; Liang SS; Zhang HG; Zhang Q; Zhang XK
Exp Mol Pathol; 2020 Aug; 115():104444. PubMed ID: 32335082
[TBL] [Abstract][Full Text] [Related]
10. Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB-mediated protective signaling in mice.
Xia Y; Rao J; Yao A; Zhang F; Li G; Wang X; Lu L
Eur J Pharmacol; 2012 Dec; 697(1-3):117-25. PubMed ID: 23051669
[TBL] [Abstract][Full Text] [Related]
11. Carnosic acid nanoparticles suppress liver ischemia/reperfusion injury by inhibition of ROS, Caspases and NF-κB signaling pathway in mice.
Li H; Sun JJ; Chen GY; Wang WW; Xie ZT; Tang GF; Wei SD
Biomed Pharmacother; 2016 Aug; 82():237-46. PubMed ID: 27470360
[TBL] [Abstract][Full Text] [Related]
12. NLRC5 deficiency promotes myocardial damage induced by high fat diet in mice through activating TLR4/NF-κB.
Ma SR; Xie XW
Biomed Pharmacother; 2017 Jul; 91():755-766. PubMed ID: 28499247
[TBL] [Abstract][Full Text] [Related]
13. Maresin 1 protects the liver against ischemia/reperfusion injury via the ALXR/Akt signaling pathway.
Tang D; Fu G; Li W; Sun P; Loughran PA; Deng M; Scott MJ; Billiar TR
Mol Med; 2021 Feb; 27(1):18. PubMed ID: 33632134
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine kinase 1 knockout alleviates hepatic ischemia/reperfusion injury by attenuating inflammation and oxidative stress in mice.
Qiang GH; Wang ZX; Ji AL; Wu JY; Cao Y; Zhang G; Zhang YY; Jiang CP
Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):255-265. PubMed ID: 31027910
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor.
Sha J; Zhang H; Zhao Y; Feng X; Hu X; Wang C; Song M; Fan H
Toxicol Appl Pharmacol; 2019 Feb; 364():144-152. PubMed ID: 30597158
[TBL] [Abstract][Full Text] [Related]
16. Alpinetin protects against hepatic ischemia/reperfusion injury in mice by inhibiting the NF-κB/MAPK signaling pathways.
Pan J; Chen S; Guo W; Cao S; Shi X; Zhang J; Zhang H; Zhang S
Int Immunopharmacol; 2021 Jun; 95():107527. PubMed ID: 33743314
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats.
Bao N; Dai D
Mediators Inflamm; 2020; 2020():2120971. PubMed ID: 32317860
[TBL] [Abstract][Full Text] [Related]
18. Role of TLR-4/IL-6/TNF-α, COX-II and eNOS/iNOS pathways in the impact of carvedilol against hepatic ischemia reperfusion injury.
Hassan MI; Ali FE; Shalkami AS
Hum Exp Toxicol; 2021 Aug; 40(8):1362-1373. PubMed ID: 33655798
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Dexmedetomidine on Abdominal Aortic Occlusion-Induced Ovarian Injury via Oxidative Stress and Apoptosis.
Mercantepe F; Tumkaya L; Mercantepe T; Akyildiz K; Ciftel S; Yilmaz A
Cells Tissues Organs; 2023; 212(6):554-566. PubMed ID: 37339613
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the P38-MAPK/TXNIP signaling activation in streptozotocin induced diabetic rats.
Yeda X; Shaoqing L; Yayi H; Bo Z; Huaxin W; Hong C; Zhongyuan X
Acta Cir Bras; 2017 Jun; 32(6):429-439. PubMed ID: 28700004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
